The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.

Activated T lymphocytes are present in human atherosclerotic lesions and autoantibodies to antigens within lesions have been detected in serum, but the roles of the cellular and humoral immune systems in atherogenesis have not been determined. The effect of total lymphocyte deficiency on atherogenesis was investigated by crossing apo E-deficient mice (which develop atherosclerosis resembling human disease) with mice deficient in RAG2 (which is required for normal B and T lymphocyte development). Mice were placed on a fat- and cholesterol-enriched diet for 12 wk. RAG2-deficient mice had no serum autoantibodies, in contrast to the high titers in RAG2+/- littermates. There were no T lymphocytes and a markedly reduced number of MHC class II-positive macrophages in atherosclerotic lesions of RAG2-deficient mice. Despite these differences, RAG2-deficient mice developed atherosclerosis similar in extent to that in immunocompetent littermates, based on quantification by two independent methods. In conclusion, the absence of autoantibodies and T lymphocytes did not influence the extent of aortic atherosclerotic lesions in apo E-deficient mice.

[1]  J. D. Smith,et al.  Mouse models of atherosclerosis. , 1998, Laboratory animal science.

[2]  J. D. Smith,et al.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Bell,et al.  Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. , 1996, The American journal of pathology.

[4]  A. Daugherty,et al.  Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[5]  M. Cybulsky,et al.  Immunology of atherosclerosis: the promise of mouse models. , 1996, The American journal of pathology.

[6]  G. Hansson,et al.  Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. , 1996, The American journal of pathology.

[7]  D. L. Fletcher,et al.  Immunologic basis of transplant-associated arteriosclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E M Rubin,et al.  Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. , 1995, Journal of lipid research.

[9]  S. Young,et al.  Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[10]  G. Schonfeld,et al.  Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. , 1995, The Journal of clinical investigation.

[11]  P. Tipping,et al.  Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit. , 1995, Atherosclerosis.

[12]  J. Campbell,et al.  T lymphocytes affect smooth muscle cell phenotype and proliferation. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[13]  P. M. Davis,et al.  Immune complexes of LDL induce atherogenic responses in human monocytic cells. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Daugherty,et al.  Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. , 1995, Cardiovascular research.

[15]  E. Miller,et al.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Qiao,et al.  Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. , 1994, The Journal of clinical investigation.

[17]  S. Gordon,et al.  Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. , 1994, Immunology letters.

[18]  T. Drake,et al.  Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  P. Libby,et al.  Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  L. Fong,et al.  Inhibition of the macrophage-induced oxidation of low density lipoprotein by interferon-gamma. , 1994, Journal of lipid research.

[21]  A. Becker,et al.  Specialized membrane contacts between immunocompetent cells in human atherosclerotic plaques. , 1994, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[22]  V. Ord,et al.  ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[23]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[25]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  E. Emeson,et al.  Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. , 1993, The American journal of pathology.

[27]  N. Mackman,et al.  Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. , 1993, The Journal of clinical investigation.

[28]  P. Quesenberry,et al.  Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma. , 1993, The Journal of clinical investigation.

[29]  Qingbo Xu,et al.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.

[30]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[31]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[32]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[34]  G. Hansson,et al.  Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. , 1992, The Journal of clinical investigation.

[35]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[36]  G. Hansson,et al.  Polyclonal origin of T lymphocytes in human atherosclerotic plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[37]  S. Holm,et al.  T lymphocytes inhibit the vascular response to injury. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Hansson,et al.  Interferon‐γ Inhibits Arterial Stenosis After Injury , 1991 .

[39]  A Daugherty,et al.  The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits , 1991, British journal of pharmacology.

[40]  P. Libby,et al.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[41]  T. Shimokama,et al.  Immunohistochemical and ultrastructural demonstration of the lymphocyte-macrophage interaction in human aortic intima. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[42]  L. Fong,et al.  Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma. , 1990, The Journal of biological chemistry.

[43]  A Daugherty,et al.  Probucol attenuates the development of aortic atherosclerosis in cholesterol‐fed rabbits , 1989, British journal of pharmacology.

[44]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.

[45]  O. Kocher,et al.  Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. , 1988, Atherosclerosis.

[46]  A. Zlotnik,et al.  Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1). , 1988, Journal of immunology.

[47]  E. Emeson,et al.  T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. , 1988, The American journal of pathology.

[48]  R. Williams,et al.  Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.

[49]  J. Bluestone,et al.  Identification of a monoclonal antibody specific for a murine T3 polypeptide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[51]  P. Steeg,et al.  Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity , 1982, The Journal of experimental medicine.

[52]  P. Edwards,et al.  Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W. Paul,et al.  A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody. , 1981, Journal of immunology.

[54]  C. Glueck,et al.  Quantitative analysis of cholesterol in 5 to 20 μl of plasma , 1974 .